Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity

Arthritis Rheumatol. 2020 Nov;72(11):1953-1955. doi: 10.1002/art.41409. Epub 2020 Sep 22.

Authors

Daniel Bertin¹, Alexandre Brodovitch², Abdou Beziane², Sylvia Hug², Afaf Bouamri², Jean Louis Mege³, Xavier Heim⁴, Nathalie Bardin⁴

Affiliations

¹ Hôpital de la Conception, AP-HM, Aix-Marseille Université, CNRS, UMR 7051 and UMR, 3916.
² Hôpital de la Conception, AP-HM.
³ Hôpital de la Conception, AP-HM, Aix-Marseille Université, IRD and Méditerranée Infection.
⁴ Hôpital de la Conception, AP-HM, Aix Marseille Université, Center for CardioVascular and Nutrition Research and INSERM UMRS 1263, Marseille, France.

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antibodies, Anticardiolipin / blood*
COVID-19 / blood
COVID-19 / diagnosis*
Female
Humans
Immunoglobulin G / blood*
Male
Middle Aged
Risk Factors
Severity of Illness Index

Substances

Antibodies, Anticardiolipin
Immunoglobulin G